{"created":"2023-05-15T14:38:25.015237+00:00","id":49583,"links":{},"metadata":{"_buckets":{"deposit":"c336bcd2-c328-4547-a555-61b4e5368de4"},"_deposit":{"created_by":1,"id":"49583","owners":[1],"pid":{"revision_id":0,"type":"depid","value":"49583"},"status":"published"},"_oai":{"id":"oai:repo.qst.go.jp:00049583","sets":["1"]},"author_link":["500827","500828","500829","500830","500824","500826","500825"],"item_8_biblio_info_7":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2020-06","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"1","bibliographicPageEnd":"91","bibliographicPageStart":"85-","bibliographicVolumeNumber":"154","bibliographic_titles":[{"bibliographic_title":"Cancer letters"}]}]},"item_8_description_5":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"This study was designed to determine the clinical implications of p21(WAF1/CIP1) expression and the relationship between p21(WAF1/CIP1) expression and p53 status in extrahepatic bile duct carcinoma (EBDC). Low p21(WAF1/CIP1) expression was immunohistochemically detected in 23 (67.6%) of 34 EBDCs, moderate in six (17.7%), and high in five (14.7%). Kaplan-Meier curves showed that low and high p21(WAF1/CIP1) expressions were significantly associated with shortened disease-free survival (low vs. moderate, P=0.02; high vs. moderate, P=0.01). There was no correlation between p21(WAF1/CIP1) and p53 expression. These findings suggest that altered p21(WAF1/CIP1) expression exerts an adverse influence on the prognosis of EBDC.","subitem_description_type":"Abstract"}]},"item_8_publisher_8":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"Elsevier Science Ireland"}]},"item_8_relation_13":{"attribute_name":"PubMed番号","attribute_value_mlt":[{"subitem_relation_type_id":{"subitem_relation_type_id_text":"10799743","subitem_relation_type_select":"PMID"}}]},"item_8_source_id_9":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"0304-3835","subitem_source_identifier_type":"ISSN"}]},"item_access_right":{"attribute_name":"アクセス権","attribute_value_mlt":[{"subitem_access_right":"metadata only access","subitem_access_right_uri":"http://purl.org/coar/access_right/c_14cb"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"Li, X"}],"nameIdentifiers":[{"nameIdentifier":"500824","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Hui, A"}],"nameIdentifiers":[{"nameIdentifier":"500825","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Takayama, T"}],"nameIdentifiers":[{"nameIdentifier":"500826","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Cui, X"}],"nameIdentifiers":[{"nameIdentifier":"500827","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Shi, Y"}],"nameIdentifiers":[{"nameIdentifier":"500828","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Makuuchi, M"}],"nameIdentifiers":[{"nameIdentifier":"500829","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"崔 星","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"500830","nameIdentifierScheme":"WEKO"}]}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"Altered p21(WAF1/CIP1) expression is associated with poor prognosis in extrahepatic bile duct carcinoma.","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"Altered p21(WAF1/CIP1) expression is associated with poor prognosis in extrahepatic bile duct carcinoma."}]},"item_type_id":"8","owner":"1","path":["1"],"pubdate":{"attribute_name":"公開日","attribute_value":"2019-02-09"},"publish_date":"2019-02-09","publish_status":"0","recid":"49583","relation_version_is_last":true,"title":["Altered p21(WAF1/CIP1) expression is associated with poor prognosis in extrahepatic bile duct carcinoma."],"weko_creator_id":"1","weko_shared_id":-1},"updated":"2023-05-15T23:19:08.637835+00:00"}